CDKN2B and breast carcinoma: ANRIL expression has also been associated with glioma, breast cancer and other malignancies [84] by epigenetically silencing the expression of the p15(INK4b), p14(ARF) and p16(INK4a) locus through its association with PRC1 and PRC2 complexes [31].